| CXSL1600092 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2017-03-01 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2017-09-27 | view |
| CXSL1700146 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2018-01-08 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2018-06-28 | view |
| CXSL1700145 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2018-01-08 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2018-06-28 | view |
| CXSL1700200 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2018-01-03 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2018-06-28 | view |
| CXSL1900059 | 重组抗PD-1人源化单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2019-06-26 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | In Review | 2019-06-25 | view |
| CXSL1900133 | 重组抗IL-5人源化单克隆抗体注射液 | Recombinant anti-IL-5 Humanized Monoclonal Antibody | Injection | Biological Products(1) | New Drug Application | 2019-11-29 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | In Review | 2019-11-28 | view |
| CXSL2000159 | 重组抗IL-4Rα人源化单克隆抗体注射液 | | Injection | Biological Products(1) | New Drug Application | 2020-07-04 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | In Review | 2020-07-02 | view |
| CXSL1900050 | 重组抗IL-17A人源化单克隆抗体注射液 | | Injection | Biological Products(1) | New Drug Application | 2019-05-30 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | In Review | 2019-05-29 | view |
| CXSL2100086 | 重组抗EGFR人鼠嵌合单克隆抗体注射液 | Recombinant anti-EGFR human-mouse chimeric monoclonal antibody | Injection | Biological Products(2.2) | New Drug Application | 2021-03-09 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | In Review | 2021-03-08 | view |
| CXSS1900033 | 重组人II型肿瘤坏死因子受体-抗体融合蛋白注射液 | | Injection | Biological Products(13) | New Drug Application | 2019-08-06 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2021-07-05 | view |
| CXSL1700058 | 注射用重组抗HER2人源化单抗-DM1偶联物 | recombinant humanized anti-HER2 mAb-DM1 | Lyophilized | Biological Products(2) | New Drug Application | 2017-08-24 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | In Review | 2017-08-22 | view |
| CXSS1800023 | 注射用重组抗HER2人源化单克隆抗体 | Recombinant humanized monoclonal antibody against HER2 | Lyophilized | Biological Products(2) | New Drug Application | 2018-09-10 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2020-06-22 | view |
| CXSL2100069 | 注射用SSGJ-612 | SSGJ-612 | Lyophilized | Biological Products(1) | New Drug Application | 2021-02-25 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | In Review | 2021-02-24 | view |
